Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests

Drug-induced liver injury (DILI) is a rare but potentially severe adverse drug event, which is also a major cause of study cessation and market withdrawal during drug development. Since no acknowledged diagnostic tests are available, DILI diagnosis poses a major challenge both in clinical practice a...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Sabine, Gerbes, Alexander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181520/
https://www.ncbi.nlm.nih.gov/pubmed/35682731
http://dx.doi.org/10.3390/ijms23116049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181520/
https://www.ncbi.nlm.nih.gov/pubmed/35682731
http://dx.doi.org/10.3390/ijms23116049

Ejemplares similares